Identification of an LtB4-protein complex as evidence of endothelial cell cytotoxic activity (ECA) in progressive systemic sclerosis (PSS).
A low molecular weight LtB4-carrier complex has been identified as endothelial cytotoxic activity (ECA) in progressive systemic sclerosis (PSS) patients' sera. ECA is thought to play a key role in the initiation of obliterative vasculopathy, a basic tissue lesion of this disease.